WebApr 12, 2024 · Other reported manifestations are thrombotic microangiopathy (TMA) and anemia due to the deficit of erythropoietin . ... In this case, the standard approach to avoid cisplatin-induced nephrotoxicity and the consequent electrolyte alteration is the administration of IV isotonic saline solution in order to stimulate the diuresis. Some …
Did you know?
WebMar 22, 2024 · Aminoglycosides preferentially affect the proximal tubular cells. These agents are freely filtered by the glomeruli and quickly taken up by the proximal tubular epithelial cells, where they are... WebThrombotic microangiopathy (TMA) is a serious toxicity associated with a small number of antineoplastic agents. A case report of a patient with probable cisplatin and bleomycin …
WebJan 11, 2024 · Cisplatin and other platinum(II) analogs are widely used in clinical practice as anti-cancer drugs for a wide range of tumors. The primary mechanism by which they … WebDec 1, 2015 · In the kidney, TMA appears as endocapillary cell swelling, fibrin thrombi, platelet plugs, arterial intimal fibrosis, and membranoproliferation. Many chemotherapeutic agents, including mitomycin, bleomycin, cisplatin, and 5-fluorouracil, can induce TMA, but the precise pathophysiology is unknown.
WebTMA is characterized by microvascular damage of arterioles and small arteries, which are occluded by eosinophilic hyaline thrombi containing fibrin and platelet aggregates, as well as by glomerular mesangiolysis, and subendothelial space widening with endothelial cells detaching from the glomerular basement membrane. , WebJan 12, 2024 · There are no structural similarities between gemcitabine and other chemotherapeutic drugs that have been implicated in the pathogenesis of TMA, such as …
WebMar 13, 2024 · Background. Cisplatin (cis-diamminedichloroplatinum II, CDDP) is one of the most effective chemotherapeutic agents. However, its clinical use is limited due to the …
WebApr 21, 2024 · Refer to UpToDate topics on cisplatin nephrotoxicity. Thrombotic microangiopathy: TMA (also sometimes called thrombotic thrombocytopenic purpura … how do you get hoopa unboundWebZurück zum Zitat Izzedine H, Isnard-Bagnis C, Launay-Vacher V, Mercadal L, Tostivint I, Rixe O et al (2006) Gemcitabine-induced thrombotic microangiopathy: a systematic review. Nephrol Dial Transplant 21(11):3038–3045 CrossRefPubMed Izzedine H, Isnard-Bagnis C, Launay-Vacher V, Mercadal L, Tostivint I, Rixe O et al (2006) Gemcitabine … how do you get horns in minecraftWebPlatinum, the Synergistic Drug: From Clinical Evidence to Laboratory Suggestions.- Chemotherapy of Mammary Cancer with Anthracyclins and Alkylators.- The Pharmaceutical Stabilization of the Clinical Anticancer Drug Dach-Platinum-TMA (NSC271674).- A Clinical Study of Reduced Glutathione as a Protective Agent Against Cisplatin-Induced Toxicity.- how do you get home equity line of creditWebJul 1, 2024 · Platinum-based drugs are alkylating agents frequently used in Oncology. Nephrotoxicity, whereas uncommon, is a major adverse effect [40]. Cisplatin-induced … phoenix trial ibrutinibWebNov 10, 2008 · One drug commonly implicated in inducing TMA is the immunosuppressant cyclosporine A (CyA). CyA-induced TMA is seen often in transplant patients (solid or liquid), but also in patients treated for rheumatoid arthritis and uveitis. The mechanism is believed to be a dose-related toxicity. how do you get hookworm infectionWebSep 1, 2024 · Cisplatin-induced TMA is associated with poor outcomes and does not have an established treatment.22 Mild proteinuria (<500 mg/d) can also be observed after treatment with high-dose cisplatin and is primarily of tubular origin.16,23 Table 1. Nephrotoxicity Associated With Platinum-Based Chemotherapeutics phoenix trinityWebFor drugs like capecitabine, etoposide, carboplatin, cisplatin, mitomycin, methotrexate, pemetrexed, pentostatin, topotecan, and bleomycin, which are largely excreted by the … phoenix trim a tree